Health Care & Life Sciences » Pharmaceuticals | Hainan Honz Pharmaceutical Co. Ltd.

Hainan Honz Pharmaceutical Co. Ltd. | Ownership

Companies that own Hainan Honz Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Hwabao Trust Co., Ltd. (Investment Portfolio)
21,779,932
5.01%
21,779,932
1.63%
09/30/2017
Beijing YongRui Fortune Investment Management Co. Ltd.
4,387,910
1.01%
4,387,910
100%
09/30/2017
Hwabao WP Fund Management Co., Ltd.
1,343,135
0.31%
1,337,285
0.05%
12/31/2017
China Universal Asset Management Co., Ltd.
999,950
0.23%
110,050
0.01%
12/31/2017
E Fund Management Co., Ltd.
270,000
0.06%
270,000
0%
12/31/2017
GF Fund Management Co., Ltd.
202,850
0.05%
30,300
0%
12/31/2017
China Southern Asset Management Co., Ltd.
7,400
0%
-104,500
0%
12/31/2017
CCB Principal Asset Management Co., Ltd.
500
0%
500
0%
12/31/2017
Lion Fund Management Co., Ltd.
0
0%
-599,950
0%
12/31/2017
Penghua Fund Management Co., Ltd.
0
0%
-2,250
0%
12/31/2017

About Hainan Honz Pharmaceutical Co.

View Profile
Address
No. 6 Yaogu Third Road
Haikou Hainan 570311
China
Employees -
Website http://www.honz.com.cn
Updated 07/08/2019
Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. It offers western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant, and arresting convulsion drugs. Its products include nimesulide granules, cefminox sodium for injection, zhike juhong granules, ganmao qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, jianerle granules, pediatric vitamins, calcium gluconate granules, ribavirin pellets, and Norfloxacin capsules for adults.